Main FDA ensures the safety of regulated products in part by performing laboratory analyses that monitor compliance with its regulations. If foods, dietary supplements or cosmetics are found to contain potentially unsafe contaminants during FDA laboratory analyses then the analytical packages must be reviewed to determine if they support regulatory action. Improving the efficiency of analytical regulatory package reviews will speed enforcement actions and more rapidly ensure the safety of U.S. foods, dietary supplements and cosmetics by removing potentially harmful products from the marketplace. <i>Information is current as of March 31, 2013.</i> Percentage line 0 100

FY 2010 9-Month Overall: 94%

Oct-Dec 2009 N/A Jan-Mar 2010 100 Apr-Jun 2010 100 Jul-Sep 2010 91 0 100

FY 2011 Overall: 92%

Oct-Dec 2010 90 87 Jan-Mar 2011 90 99 Apr-Jun 2011 90 91 Jul-Sep 2011 90 91 0 100

FY 2012 Overall: 95%

Oct-Dec 2011 90 98 Jan-Mar 2012 90 94 Apr-Jun 2012 90 93 Jul-Sep 2012 90 94 0 100

FY 2013 YTD: 95%

Oct-Dec 2012 90 97 Jan-Mar 2013 90 94 Apr-Jun 2013 90 Jul-Sep 2013 90 Sub Percentage of analytical package reviews received via FDA's electronic Compliance Management System (CMS) that meet Office of Compliance (OC) timeframes as specified in CMS in the quarter Number column

FY 2010 9-Month Total: 95

Oct-Dec 2009 N/A Jan-Mar 2010 5 Apr-Jun 2010 32 Jul-Sep 2010 58

FY 2011 Total: 238

Oct-Dec 2010 48 Jan-Mar 2011 69 Apr-Jun 2011 63 Jul-Sep 2011 58 0 100

FY 2012 Total: 366

Oct-Dec 2011 92 Jan-Mar 2012 84 Apr-Jun 2012 108 Jul-Sep 2012 82 0 100

FY 2013 YTD: 169

Oct-Dec 2012 87 Jan-Mar 2013 82 Apr-Jun 2013 Jul-Sep 2013 Sub Percentage of analytical package reviews received via FDA's electronic Compliance Management System (CMS) that meet Office of Compliance (OC) timeframes as specified in CMS in the quarter Number column

FY 2010 9-Month Total: 101

Oct-Dec 2009 N/A Jan-Mar 2010 5 Apr-Jun 2010 32 Jul-Sep 2010 64

FY 2011 Total: 258

Oct-Dec 2010 55 Jan-Mar 2011 70 Apr-Jun 2011 69 Jul-Sep 2011 64 0 100

FY 2012 Total: 386

Oct-Dec 2011 94 Jan-Mar 2012 89 Apr-Jun 2012 116 Jul-Sep 2012 87 0 100

FY 2013 YTD:177

Oct-Dec 2012 90 Jan-Mar 2013 87 Apr-Jun 2013 Jul-Sep 2013 http://www.fda.gov/AboutFDA/Transparency/track/ucm206221.htmFDA-TRACK CFSAN Dashboard ਍††਍਍਍਍਍਍਍